Cyclopiazonic acid, an inhibitor of calcium-dependent ATPases with antiviral activity against human respiratory syncytial virus
- 1 August 2016
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 132, 38-45
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31400148)
- Science and Technology Commission of Shanghai Municipality (14YF1407600)
This publication has 42 references indexed in Scilit:
- A Historical Overview of Natural Products in Drug DiscoveryMetabolites, 2012
- Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these yearsVirus Research, 2011
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysisThe Lancet, 2010
- Natural products in drug discoveryDrug Discovery Today, 2008
- RSV604, a Novel Inhibitor of Respiratory Syncytial Virus ReplicationAntimicrobial Agents and Chemotherapy, 2007
- Intracellular disassembly of infectious rotavirus particles by depletion of Ca2+ sequestered in the endoplasmic reticulum at the end of virus cycleVirus Research, 2007
- Involvement of endoplasmic reticulum in hepatitis B virus replicationVirus Research, 2006
- Respiratory Syncytial Virus Infection in Elderly and High-Risk AdultsNew England Journal of Medicine, 2005
- Prevalence of Respiratory Syncytial Virus Subgroups Over Six Consecutive Outbreaks: 1981-1987The Journal of Infectious Diseases, 1989
- Occurrence of respiratory syncytial virus subtypes a and b strains in swedenJournal of Medical Virology, 1986